ERBB2 and breast cancer: ERBB2, overexpressed in 25 to 30% of human breast cancers [11], [12], is associated with metastasis [13], and ERBB2-overexpressing cells are self-sufficient with respect to, anchorage-independent growth and efficient in invasion [14].